A, D. C., M, P., G, G., M, B., C, Z., F, F., . . . M, S. (2022). Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. Journal of personalized medicine, 12(4), . https://doi.org/10.3390/jpm12040565
Chicago Style (17th ed.) CitationA, Del Casale, et al. "Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders." Journal of Personalized Medicine 12, no. 4 (2022). https://doi.org/10.3390/jpm12040565.
MLA (9th ed.) CitationA, Del Casale, et al. "Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders." Journal of Personalized Medicine, vol. 12, no. 4, 2022, https://doi.org/10.3390/jpm12040565.